The Secretary of State for Health was asked (Hansard 24 May 1999 at column 21) what assessment the Department of Health (DoH) has made of the social costs and benefits of Aricept for Alzheimer’s patients and the savings in respite and other long term care resulting from the use of Aricept.Mr Hutton replied that the…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2025 All rights reserved LaingBuisson 
